Principles of Conservative Prescribing

被引:83
作者
Schiff, Gordon D. [1 ]
Galanter, William L. [2 ]
Duhig, Jay [3 ]
Lodolce, Amy E. [4 ]
Koronkowski, Michael J. [4 ]
Lambert, Bruce L. [3 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Patient Safety Res & Practice,Div Gen Med, Boston, MA 02130 USA
[2] Univ Illinois, Coll Med, Dept Med, Chicago, IL USA
[3] Uivers Illinois Chicago Coll Pharm, Dept Pharm Adm, Chicago, IL USA
[4] Uivers Illinois Chicago Coll Pharm, Dept Pharm Practice, Chicago, IL USA
基金
美国医疗保健研究与质量局;
关键词
SURROGATE END-POINTS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CLINICAL-TRIAL; HEART-FAILURE; MEDICATION NONADHERENCE; PRIMARY PREVENTION; RISK-FACTORS; LIFE-STYLE; THERAPY; OUTCOMES;
D O I
10.1001/archinternmed.2011.256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Judicious prescribing is a prerequisite for safe and appropriate medication use. Based on evidence and lessons from recent studies demonstrating problems with widely prescribed medications, we offer a series of principles as a prescription for more cautious and conservative prescribing. These principles urge clinicians to (1) think beyond drugs (consider nondrug therapy, treatable underlying causes, and prevention); (2) practice more strategic prescribing (defer nonurgent drug treatment; avoid unwarranted drug switching; be circumspect about unproven drug uses; and start treatment with only 1 new drug at a time); (3) maintain heightened vigilance regarding adverse effects (suspect drug reactions; be aware of withdrawal syndromes; and educate patients to anticipate reactions); (4) exercise caution and skepticism regarding new drugs (seek out unbiased information; wait until drugs have sufficient time on the market; be skeptical about surrogate rather than true clinical outcomes; avoid stretching indications; avoid seduction by elegant molecular pharmacology; beware of selective drug trial reporting); (5) work with patients for a shared agenda (do not automatically accede to drug requests; consider nonadherence before adding drugs to regimen; avoid restarting previously unsuccessful drug treatment; discontinue treatment with unneeded medications; and respect patients' reservations about drugs); and (6) consider long-term, broader impacts (weigh long-term outcomes, and recognize that improved systems may outweigh marginal benefits of new drugs). Arch Intern Med. 2011; 171(16): 1433-1440. Published online June 13, 2011. doi: 10.1001/archinternmed.2011.256
引用
收藏
页码:1433 / 1440
页数:8
相关论文
共 130 条
  • [1] Allison DB, 1999, AM J PSYCHIAT, V156, P1686
  • [2] The effect of electronic prescribing on medication errors and adverse drug events: A systematic review
    Ammenwerth, Elske
    Schnell-Inderst, Petra
    Machan, Christof
    Siebert, Uwe
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2008, 15 (05) : 585 - 600
  • [3] Angel M, BIG PHARMA BAD MED C
  • [4] Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial
    Ardeshna, KM
    Smith, P
    Norton, A
    Hancock, BW
    Hoskin, PJ
    MacLennan, KA
    Marcus, RE
    Jelliffe, A
    Hudson, GV
    Linch, DC
    [J]. LANCET, 2003, 362 (9383) : 516 - 522
  • [5] Watchful waiting and health related quality of life for patients with localized prostate cancer: Data from CaPSURE (Reprinted from The Journal of Urology, vol 172, pg 1830-1834, 2004)
    Arredondo, Shelley A.
    Downs, Tracy M.
    Lubeck, Deborah P.
    Pasta, David J.
    Silva, Stefanie J.
    Wallace, Katrine L.
    Carroll, Peter R.
    [J]. JOURNAL OF UROLOGY, 2008, 179 (05) : S14 - S18
  • [6] Subgroup analysis and other (mis)uses of baseline data in clinical trials
    Assmann, SF
    Pocock, SJ
    Enos, LE
    Kasten, LE
    [J]. LANCET, 2000, 355 (9209) : 1064 - 1069
  • [7] Association of American Medical Colleges, 2008, CONT ISS MED ED SAF
  • [8] Avorn Jerry., 2004, Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs
  • [9] BACIU A, 2007, FUTURE DRUG SAFETY P
  • [10] Does chronic daily headache arise de novo in association with regular use of analgesics?
    Bahra, A
    Walsh, M
    Menon, S
    Goadsby, PJ
    [J]. HEADACHE, 2003, 43 (03): : 179 - 190